Try our beta test site
661 studies found for:    Northwestern AND Lung
Show Display Options
Rank Status Study
1 Recruiting Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   ILD;   Systemic Sclerosis;   Scleroderma
Interventions: Drug: Bortezomib;   Drug: Placebo;   Drug: Mycophenolate mofetil
2 Active, not recruiting Lung Function Decline and Disease Risk From Young Adulthood to Middle Age
Conditions: COPD;   Lung Function;   Heart - Lung Interaction;   Restrictive Lung Disease
Interventions: Procedure: Lung spirometry;   Other: CT scan analysis
3 Completed Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
Condition: Advanced Nonsmall Cell Lung Cancer
Intervention:
4 Terminated Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Conditions: Metastatic Non Small Cell Lung Cancer;   Metastatic Breast Cancer
Interventions: Drug: Pazopanib;   Drug: Vinorelbine
5 Not yet recruiting Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage III Non-Small Cell Lung Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride;   Biological: Nivolumab
6 Active, not recruiting Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Non-small Cell Lung Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: Hsp90 inhibitor AUY922;   Other: laboratory biomarker analysis;   Procedure: needle biopsy;   Genetic: mutation analysis;   Other: pharmacological study
7 Completed Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers
Conditions: Asthma;   Lung Diseases
Intervention: Behavioral: Asthma Disparity Reduction Strategy
8 Completed
Has Results
Ranolazine and Pulmonary Hypertension
Conditions: Angina;   Pulmonary Arterial Hypertension
Intervention: Drug: Ranolazine
9 Terminated Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: chemoprotection;   Drug: paclitaxel;   Radiation: radiation therapy
10 Withdrawn The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD
Conditions: Chronic Obstructive Pulmonary Disease;   Sleep Disorders
Intervention: Drug: salmeterol-fluticasone
11 Active, not recruiting Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: pemetrexed
12 Active, not recruiting A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
Condition: Bronchiolitis Obliterans
Intervention: Drug: Bortezomib
13 Completed Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: vinorelbine ditartrate
14 Terminated Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: Gemcitabine;   Drug: paclitaxel;   Drug: vinorelbine;   Radiation: radiation therapy;   Drug: Navelbine;   Drug: Taxol
15 Completed Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: celecoxib;   Drug: docetaxel;   Drug: irinotecan hydrochloride
16 Completed Prospective Study of Ventral Hernia Repair
Condition: Ventral Hernia
Intervention: Procedure: Components separation hernia repair
17 Completed Oltipraz in the Prevention of Lung Cancer in People Who Smoke
Condition: Lung Cancer
Intervention: Drug: oltipraz
18 Unknown  Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Emphysema;   Endothelial Dysfunction
Intervention:
19 Completed Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer;   Lung Cancer
Interventions: Drug: celecoxib;   Procedure: adjuvant therapy
20 Recruiting Iloprost in Preventing Lung Cancer in Former Smokers
Conditions: Lung Carcinoma;   Mild Dysplasia;   Precancerous Condition
Interventions: Drug: Iloprost;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.